European life-science infrastructure for biological information
ELIXIR was established in 2014 as an intergovernmental organisation to ensure sustained life science resources across Europe. It presently includes 21 members and covers over 180 research organisations. ELIXIR unites Europe’s leading life science organisations in managing and safeguarding the increasing volume of data being generated by publicly funded research. ELIXIR coordinates, integrates and sustains bioinformatics resources across its member states and European Molecular Biology Laboratory and enables users in academia and industry to access services that are vital for their research.
The scientific and technical activities in ELIXIR are organised in five Platforms Data, Compute, Interoperability, Tools and Training and scientific Communities. Platforms bring together experts to define the strategy and provide services in a particular area e.g. training, data. Communities bring together scientists who work in a specific domain (e.g. Plant Sciences). Scientists develop services targeted for their own domains and give feedback on the services the Platforms provide, to make sure that the services solve real world problems.
The Finnish ELIXIR Node is operated by CSC and plays a fundamental part in broader life science research infrastructure in Europe, e.g. providing cloud computing for European biomedical organizations, for easing international access to Finnish biobanks and supporting the creation of a catalogue of national genetic variation. CSC also leads the ELIXIR Compute platform, one of the five ELIXIR platforms, with the Czech Node and EMBL-EBI. CSC plays a significant role in the ELIXIR sensitive data strategy and implementation. For example, federated user identity and access management systems including handling of access to sensitive biological data have been enabled with information technology (REMS) created by CSC.
R&D projects related to ELIXIR programme
The Beyond 1 Million Genomes (B1MG) project is helping to create a network of genetic and clinical data across Europe. The project provides coordination and support to the 1+ Million Genomes Initiative (1+MG). This initiative will go 'beyond' the 1+MG Initiative by creating long-term means of sharing data beyond 2022, and enabling access to beyond 1 million genomes.Lue lisää »
BIGPICTURE, a pathology-led project, has the vision to become the catalyst in digital transformation in Pathology. Our mission is to create the first European GDPR compliant platform, in which both quality-controlled Whole Slide Imaging (WSI) data and advanced Artificial intelligence (AI) algorithms will exist.Lue lisää »
CINECA aims to provide a standardized, secure and scalable discovery and analysis infrastructure for data collected from the national cohorts and disease collections. The CINECA consortium includes access to more than 1.4 million samples maintained by the biobank network in Europe, Africa and CanadaLue lisää »
The European Joint Programme on Rare Diseases brings over 130 institutions from 35 countries to create a comprehensive, sustainable ecosystem allowing a virtuous circle between research, care and medical innovation.Lue lisää »
ELIXIR-CONVERGE is a project funded by the European Commission to help standardise life science data management across Europe. To achieve this standardisation, the project will develop a data management toolkit for life scientists.Lue lisää »
EOSC-Life intends to implements the Life Science part of the European Open Science Cloud under coordination of ELIXIR, European infrastructure for Life Science Information. EOSC-Life brings together the 13 Biological and Medical ESFRI research infrastructures (BMS RIs) to create an open collaborative space for digital biology.Lue lisää »
HEAP will provide a research resource for the integrated and efficient analysis of the human exposome. HEAP will launch a state-of-the-science informatics infrastructure (IaaS) composed of prime ICT resources from partner institutions in several EU countries, accessed through a software platform (PaaS) that includes the world’s fastest Hadoop platform to provide data warehousing and applied AI.Lue lisää »
The aim of INTERVENE is to build the largest pool of health data to date and integrate longitudinal and disease-relevant -omics data into genetic risk scores with unprecedented potential for prediction, prognosis, and personalised treatments of complex and rare diseases.Lue lisää »
The HPC/Exascale Centre of Excellence in Personalised Medicine (PerMedCoE) aims to provide an efficient and sustainable entry point to the HPC/Exascale-upgraded methodology to translate omics analyses into actionable models of cellular functions of medical relevance. Simulation of cellular mechanistic models are essential for the translation of omic data to medical relevant actions and these should be accessible to the end-users in the appropriate environment of the PerMed-specific big confidential data.Lue lisää »